| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9871e02d1c09cc338f51aecbb5510178 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a810b24307f28ad40a42ac2ad6966c08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c38c64788b64defd3ab5ecb405c2a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73ea9795f31a2ce99c77ffda1d4a54a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ab3a21fb6a9a1c01563876efd717c8f |
| publicationDate |
2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2014185165-A |
| titleOfInvention |
Human monoclonal antibody against epidermal growth factor receptor |
| abstract |
The present invention provides a human monoclonal antibody for treating solid cancer by antibody therapy with an antibody against human epidermal growth factor receptor (EGF-r). A fully human monoclonal antibody against human epidermal growth factor receptor (EGF-r) is provided. Nucleotide sequences encoding heavy and light chain immunoglobulin molecules and amino acid sequences containing the molecules, particularly sequences corresponding to adjacent heavy and light chain sequences from CDR1 to CDR3, are provided. Hybridomas expressing such immunoglobulin molecules and monoclonal antibodies are also provided. [Selection figure] None |
| priorityDate |
1997-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |